
    
      A randomised, double-blind, parallel group study to investigate the efficacy and safety of
      treatment with Dutasteride (0.5 mg) and Tamsulosin (0.4 mg), administered once daily for 4
      years, alone and in combination, on the improvement of symptoms and clinical outcome in men
      with moderate to severe symptomatic benign prostatic hyperplasia.
    
  